Phase 1 dog trials to commence 19th of February 2019.
Excellent progress with agreed US site.
Furthermore, the completion of 2000 tablets ( required for the study) at hand.
Criterion based assessment for both dog and human further trials with IND and FDA checkpoints in mind.
Well done to the entire PAA team on both market awareness and strategic foresight.
Ann: PharmAust Signs Agreement for US Phase I Trials in Dogs, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $1.507K | 8.867K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 172806 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 469358 | 9 |
View Market Depth
| Last trade - 10.06am 18/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |